FDA Approves Duodenoscope With Disposable Elevator Piece

Article

A duodenoscope that has a sterile disposable elevator component has been cleared for market and represents an important step in the fight against infection, according to the US Food and Drug Administration (FDA). The elevator component can be a breeding ground for infectious contamination if not cleaned properly, and that’s traditionally been a difficult process because it has so many parts.

Jeff Shuren, MD, director of the FDA’s Center for Devices and Radiological Health, in a press release called the approval a “major step toward lowering the risk of infection among patients who undergo procedures with these devices.”

Duodenoscopes are used in endoscopic retrograde cholangiopancreatography (ERCP) procedures; there are about 500,000 such procedures each year. They’re less invasive than traditional surgery in draining fluids from pancreatic and biliary ducts blocked by cancerous tumors or gallstones.The elevator part of the duodenoscope facilitates access to the bile and pancreatic ducts and is used to position endoscopic instruments during the procedure.

The FDA wants hospitals and other healthcare facilities to begin using devices with disposable componentsas soon as possible. The particular device the FDA approved is called the Pentax Medical Video Duodenoscope ED34-i10T2. PentaxMedical is a global corporation that manufactures endoscopic products. 

The announcement does not come as a complete surprise. In August, the FDA asked that duodenoscope manufacturers and healthcare facilities transition to duodenoscopes with disposable components.“Disposable designs can simplify or eliminate the need for reprocessing of certain components, which may reduce between-patient duodenoscope contamination,” the agency said in its approval announcement. 

The FDA has previously cleared duodenoscopes with removable endcap components. 

Recent Videos
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Related Content